pharmaphorum

MARCH 23, 2022

Argenx only recently scored FDA approval for its intravenous anti-neonatal FC receptor (FcRn) antibody Vyvgart for generalised myasthenia gravis (gMG), but is already looking to defend its franchise with a new subcutaneous version of the drug. in the injectable group and down 62.2% in the IV arm.

FDA 52

FDA 52

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. Oral therapy data presented at ASH. CellCentric, a U.K-based

Immunization 52

Immunization Hospitals Vaccines 52

pharmaphorum

MAY 17, 2021

Empaveli’s label covers treatment-naïve PNH patients as well as those who want to switch from Soliris or Ultomiris, and is based on the phase 3 PEGASUS trial in 80 patients which compared the drug to Soliris over a 16-week period. The post Apellis set to take on Alexion as FDA clears PNH drug Empaveli appeared first on.

FDA 52

FDA Labelling Vaccines 52

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Communication 91

Communication Insurance Packaging Pharmaceutical Companies 91

pharmaphorum

JUNE 2, 2021

NICE has rejected routine NHS funding for Roche’s Evrysdi (risdiplam) for spinal muscular atrophy drug in draft guidance, a decision which doesn’t come as a surprise to patient association SMA UK. Comments can be submitted until 23 June. — Spinal Muscular Atrophy UK (@SMA_UK_) June 2, 2021.

Documentation 52

Documentation Communication 52

The Checkup by Singlecare

NOVEMBER 2, 2023

These drugs mimic GLP-1, a hormone responsible for regulating appetite and food intake, leading to weight loss and improved control of blood sugar levels in people with Type 2 diabetes. These are the benefits of GLP-1 drugs , beyond blood sugar control. Rising demand for GLP-1 drugs: Why are they so popular?

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

pharmaphorum

DECEMBER 2, 2020

The company’s first product, a palatable anti-parasitic drug, made to taste like toffee, united Pfizer’s skills as a chemist with Erhart’s training as a confectioner. The “first industrial war” involved drug producers as much as weapons manufacturers. It was a success, and set the pattern for the company’s future development.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

Pharmaceutical Technology

APRIL 5, 2023

More than a decade after the first patient was treated with a CAR-T therapy, six therapies relying on the same principles have been approved by the US Food and Drug Administration (FDA) and marketed to thousands of patients. With blood cancers, you inject the product, and the cells are there, and the target is there.

FDA 59

FDA Immunization 59

The Checkup by Singlecare

MARCH 21, 2023

Opioids are prescription drug painkillers that are typically reserved for certain types of moderate to severe and sometimes chronic pain , and rarely for acute pain that is unresponsive to non-opioid medications like non-steroidal anti-inflammatory drugs ( NSAIDs ), Tylenol ( acetaminophen ), and certain antidepressants or anti-seizure medications.

Dosage 52

Dosage Controlled Substances Labelling Packaging 52

The Checkup by Singlecare

JUNE 21, 2023

The condition causes higher levels of androgen hormone production, resulting in symptoms such as irregular menstrual cycles, acne, excess hair growth, cysts, skin tags, thinning hair, skin darkening, and infertility. There is no FDA-approved generic version of semaglutide injection currently available. Is Ozempic good for PCOS?

Insurance 98

Insurance FDA Compounding Compounding Pharmacies 98

The Checkup by Singlecare

MARCH 7, 2024

Ozempic (semaglutide) is a weekly injectable drug that lowers blood sugar levels. It was approved by the Food and Drug Administration (FDA) in 2017 for treating Type 2 diabetes. After a brief training session with your clinician, you should be ready to inject yourself with your weekly dose.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Packaging Insurance Coverage 52

pharmaphorum

AUGUST 26, 2022

BioMarin will no doubt have an eye on the earlier experience of bluebird bio, which secured EU approval for rare disease gene therapy Zynteglo (betibeglogene autotemcel) in 2019 for beta thalassaemia with a price tag of around €1.6 million spread over five years.

FDA 111

FDA 111

European Pharmaceutical Review

MAY 11, 2023

Three SMN-enhancing treatments for the condition are approved by the US Food and Drug Administration (FDA) 2 , however there is no cure for SMA at present. There are three modes of action (MOA) available for treatments – intrathecal injection, intravenous infusion and an oral formula. percent of Europe’s annual healthcare spend.

FDA 71

FDA 71

The Checkup by Singlecare

JANUARY 19, 2023

Depending on the severity of high blood sugar, treatment may include diet, exercise, oral or injectable medication, and in some cases, insulin. There may also be skin tags in these areas. Diabetes People with diabetes have a fasting blood sugar of 126 mg/dl or more. Symptoms of high blood sugar generally require treatment.

Immunization 105

Immunization Hospitals Communication 105